跳转至内容
Merck
CN
  • Bone and cartilage metabolism markers in synovial fluid of the hip joint with secondary osteoarthritis.

Bone and cartilage metabolism markers in synovial fluid of the hip joint with secondary osteoarthritis.

Rheumatology (Oxford, England) (2014-06-25)
Ryosuke Yamaguchi, Takuaki Yamamoto, Goro Motomura, Satoshi Ikemura, Kenyu Iwasaki, Garida Zhao, Toshio Doi, Yukihide Iwamoto
摘要

The aim of this study was to compare the levels of bone and cartilage metabolism markers in the synovial fluid of the hip joint between patients with secondary OA due to osteonecrosis of the femoral head (ONFH), rapidly destructive arthrosis (RDA) and developmental dysplasia of the hip (DDH). We studied 70 synovial fluid samples obtained from 57 patients with ONFH (mean age 46 years, 34 males, 23 females), 21 samples obtained from 21 patients with RDA (mean age 70 years, 2 males, 19 females) and 20 samples obtained from 20 patients with DDH (mean age 56 years, 2 males, 18 females). The levels of bone alkaline phosphatase (BAP) and tartrate-resistant acid phosphatase 5b (TRACP-5b), as bone metabolism markers, and matrix metalloproteinase 3 (MMP-3) and keratan sulphate (KS), as cartilage metabolism markers, were analysed. The levels of BAP, MMP-3 and KS were significantly higher in the ONFH group than in the RDA and DDH groups. The levels of TRACP-5b were highest in the RDA group. The levels of BAP in the ONFH group after the development of osteoarthritic changes were significantly lower than those observed in earlier stages. In comparisons between the samples obtained from each group with a terminal condition, the ONFH samples exhibited significantly higher MMP-3 and KS levels, while the TRACP-5 levels were highest in the RDA group. The ONFH patients showed a relatively bone formative condition before the osteoarthritic stage and maintained a higher rate of cartilage turnover throughout several stages compared with the RDA and DDH patients. RDA patients were characterized by a significantly high osteoclast activity.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
6-苄氨基嘌呤, suitable for plant cell culture
Sigma-Aldrich
酸性磷酸酶 来源于马铃薯, lyophilized powder, ≥0.5 unit/mg solid
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, buffered aqueous solution, ≥2,000 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, lyophilized powder, ≥10 DEA units/mg solid
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, BioUltra, ≥5,700 DEA units/mg protein
Sigma-Aldrich
酸性磷酸酶 来源于小麦胚芽, ≥0.4 unit/mg solid
Sigma-Aldrich
6-苄氨基嘌呤, ReagentPlus®, ≥99.0% (HPLC)
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, ≥2,000 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, lyophilized powder, 30-60 units/mg protein (in glycine buffer)
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, ≥5,500 DEA units/mg protein
Sigma-Aldrich
酸性磷酸酶 来源于马铃薯, lyophilized powder, ≥3.0 units/mg solid
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, buffered aqueous glycerol solution, 20-50 units/mg protein (in glycine buffer)
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, buffered aqueous glycerol solution, ≥4,000 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, ammonium sulfate suspension, 30-90 units/mg protein (modified Warburg-Christian, in glycine buffer)
Sigma-Aldrich
碱性磷酸酶 来源于猪肾脏, lyophilized powder, ≥100 DEA units/mg protein
Sigma-Aldrich
磷酸酶(碱性) 来源于小牛肠粘膜, suitable for enzyme immunoassay, solution (clear, colorless), ~2500 U/mg protein (~10 mg/ml)
Sigma-Aldrich
磷酸酶(酸性) 来源于甘薯, ammonium sulfate suspension, ≥10.0 units/mg protein (modified Warburg-Christian)
Sigma-Aldrich
磷酸酶,碱性虾, ≥900 DEA units/mL, buffered aqueous glycerol solution, recombinant, expressed in proprietary host
Supelco
6-苄氨基嘌呤, PESTANAL®, analytical standard
Sigma-Aldrich
磷酸酶(碱性) 牛, recombinant, expressed in Pichia pastoris, ≥4000 units/mg protein
Sigma-Aldrich
6-苄氨基嘌呤, Vetec, reagent grade, 98%